Skip to content
Subscriber Only

Europe's Drug Agency Warns of Bigger Staff Losses in Brexit Move

  • Regulator says it underestimated challenges of relocation
  • Pharma watchdog has 1,000 applicants lined up, director says
Guido Rasi
Guido RasiPhotographer: Luke MacGregor/Bloomberg

Europe’s drug watchdog is bracing for higher-than-anticipated staff departures due to its Brexit-induced move to Amsterdam, raising pressure on the agency that oversees medication safety for about 500 million people.

A host of issues, including the effect of local labor laws on short-term contracts, could boost employee losses at the European Medicines Agency beyond 19 percent, the level it estimated last year, Executive Director Guido Rasi said in an interview at its headquarters in London’s Canary Wharf district. Hitting that target will be “very challenging,” he said.